<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9"><gtr:id>3EAE04CA-9D62-4483-B9C4-F91AD9F4C5A9</gtr:id><gtr:name>University of Oxford</gtr:name><gtr:address><gtr:line1>University Chest</gtr:line1><gtr:line2>Wellington Square</gtr:line2><gtr:line4>Oxford</gtr:line4><gtr:postCode>OX1 2JD</gtr:postCode><gtr:region>South East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/38C70F3F-2A52-4436-84FB-A9F91F073FF3"><gtr:id>38C70F3F-2A52-4436-84FB-A9F91F073FF3</gtr:id><gtr:firstName>Jan</gtr:firstName><gtr:surname>Rehwinkel</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=MC_UU_12010%2F8"><gtr:id>2B79BD6E-08DA-43B0-8191-A03A90401D4D</gtr:id><gtr:title>Activation of innate nucleic acid sensing pathways during virus infection, inflammation and autoimmunity</gtr:title><gtr:status>Active</gtr:status><gtr:grantCategory>Intramural</gtr:grantCategory><gtr:grantReference>MC_UU_12010/8</gtr:grantReference><gtr:abstractText>We are trying to work out how the immune system is activated in virus infection and inflammatory disease. Cells infected by virus respond by producing anti-viral factors, which block viral replication and help to control infection. We are interested in a cell molecule called RIG-I, which detects infection with viruses such as influenza A virus. RIG-I recognizes the presence of viral genomes made of RNA. However, normal cells also contain RNA as this is the ?messenger? molecule that allows the DNA genes of cells to be copied and translated into protein. How, then, can RIG-I distinguish between the RNA of the cell and the RNA of the virus? The answer lies in a structure called a ?cap? found at the starting point of cellular RNAs. Viral RNA genomes do not have this ?cap? and RIG-I specifically responds only to RNAs lacking this structure. This is why only cells infected by viruses produce anti-viral factors. By working out how RIG-I and other receptors detect infection with a variety of viruses we aim to understand how this type of immune response is controlled. In a second line of research, we are interested in inflammatory diseases such as Aicardi-Goutieres syndrome that result of the anti-viral pathways being triggered aberrantly in the absence of infection. We hope to determine how deregulation of these pathways can result in disease and find ways of controlling inappropriate inflammatory responses.</gtr:abstractText><gtr:technicalSummary>The innate immune response is critical for successful host defence against virus infection. Cell-intrinsic mechanisms detect virus presence and signal for the induction of innate response genes such a type I interferons (IFNs) (1). Nucleic acids are often a molecular signature of virus infection and are recognised by innate receptors such as toll-like receptors and RIG-I-like receptors. In addition to their protective role in infectious disease, some of these receptors have also been implicated in inflammatory conditions. Research in my group dissects the molecular biology of activation and regulation of the innate immune receptors that sense nucleic acids both in virus infections and in inflammatory disease. Previously, we showed that progeny viral RNA genomes are recognized by RIG-I in cells infected with negative strand RNA viruses such as influenza A virus (2). These genomes bear a triphosphate moiety on the 5?-end that is essential for RIG-I activation and IFN induction (2). Such 5?-PPP-groups are absent from cellular RNA in the cytoplasm, providing an explanation for the specific triggering of RIG-I in virus-infected cells. We also contributed to projects studying the role of MDA5 and PKR in the immune response to viral infection and the induction of interferon (3,4). Currently, we are working on three complementary aspects of the sensing of nucleic acids by innate immune receptors. Firstly, by using clinically relevant viruses such as picornaviruses and hepatitis C virus, we will characterize the types of RNA recognized by RIG-I and the related receptors MDA5 and LGP2, and the mechanisms of activation of these receptors, in infected cells. Secondly, to determine how the strength and duration of the innate immune responses is controlled we will dissect the mechanisms regulating the expression of pattern recognition receptors and downstream signalling molecules at the post-transcriptional level. Thirdly, because aberrant activation of innate nucleic acid sensing pathways can lead to inflammatory diseases through the triggering of intracellular DNA and RNA sensors and the induction of type I IFN, we are studying the molecular basis of Aicardi-Goutieres syndrome. This genetic disorder mimics virus infection and is characterized by spontaneous IFN production (5). Taken together, this work at the intersection of molecular biology and immunology will provide important insights into activation of the innate immune system by nucleic acids. Our findings will have major implications for virus infection, inflammatory and autoimmune diseases and the development of vaccine adjuvants. References: (1) Rehwinkel and Reis e Sousa 2010 Science 327: 284; (2) Rehwinkel et al 2010 Cell 140: 397; (3) Schulz et al 2010 Cell Host Microbe 7:354; (4) Pichlmair et al 2009 J Virol 83: 10761; (5) Crow and Rehwinkel 2009 Hum Mol Genet 18:R130</gtr:technicalSummary><gtr:fund><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2012-04-01</gtr:start><gtr:type>EXPENDITURE_ACTUAL</gtr:type><gtr:valuePounds>2342000</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Viruses and Cancer for students</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>0520F8DD-E277-4540-8592-D9D667D78C24</gtr:id><gtr:impact>GCSC and A-level Students were introduced to the idea of virus and host interaction, that viruses can cause cancer and that basic research can be applied in cancer therapy or vaccine development. The experience was hands-on and interactive.</gtr:impact><gtr:outcomeId>56cde3a64ab6b3.66015471</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Knowing your enemy: viruses as the Trojan Horses of our immune system</gtr:description><gtr:form>A broadcast e.g. TV/radio/film/podcast (other than news/press)</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>88FEA141-8DF1-46AA-9638-04D75F169914</gtr:id><gtr:impact>Blog describing our latest findings published in Science</gtr:impact><gtr:outcomeId>56cde40be80248.93094535</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.imm.ox.ac.uk/wimm-blog-2</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>FameLab Oxford Heats 2016</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>A27E9471-EC36-4A21-B3A3-04B54CA97582</gtr:id><gtr:impact>FameLab is a science communication competition where participants have 3 minutes to explain a scientific concept or idea to a non-expert audience without the use of PowerPoint. In the first round (the Oxford Heats), Layal Liverpool, a DPhil student in the lab, talked about a recently developed protein construct that can direct activation and lysis of latently HIV-infected CD4 T-cells by killer T-cells. The entry can be viewed here: https://www.youtube.com/watch?v=pFer1Q0KqL8.</gtr:impact><gtr:outcomeId>5756eaa51a9da6.14946492</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>https://www.youtube.com/watch?v=pFer1Q0KqL8</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>FameLab Oxford Regional Final 2016</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>CEBB018C-ABA2-4F02-BCC3-29E6AABA1925</gtr:id><gtr:impact>FameLab is a science communication competition where participants have 3 minutes to explain a scientific concept or idea to a non-expert audience without the use of PowerPoint. Loyal Liverpool, a DPhil student in the lab, got through to the Oxford Regional Finals where she spoke about the discovery of ANP32A as a novel co-factor for the Influenza virus.</gtr:impact><gtr:outcomeId>5756eb07a47bf8.79701281</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Viruses and Cancer for adults</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>E9B3F069-2707-447B-9ADF-736BAC90423A</gtr:id><gtr:impact>Public was introduced to the idea of virus and host interaction, that viruses can cause cancer and that basic research can be applied in cancer therapy or vaccine development. The experience was hands-on and interactive.</gtr:impact><gtr:outcomeId>56cde35d119e71.47285385</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MRC Centenary Event</gtr:description><gtr:form>Participation in an open day or visit at my research institution</gtr:form><gtr:geographicReach>Local</gtr:geographicReach><gtr:id>49A65856-E510-4EAD-96CA-774FB18768D3</gtr:id><gtr:impact>Nature of the engagement: MRC Centenary Event (marquee); talked to public and helped with:
? A Giant nose for children to play in!
? Colouring activities
? Finding out what our blood cells do (fluffy toys)
? Looking at slides under microscopes
? Making a DNA sequence bracelet
? Obtaining DNA from strawberries 


Impact of engagement e.g. feedback given, thank you letters received etc.:
51 evaluation forms were completed, accounting for 133 people (7% of the total). Respondents' overall impression of the event was overwhelmingly positive. 50 of the 51 forms (99%) rated the event as ?. The other respondent said they were &amp;quot;interested&amp;quot;.</gtr:impact><gtr:outcomeId>URCQF3CoEz8</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>School Visit (Brazil)</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>63013865-E923-40B1-B59A-A0C841FD7232</gtr:id><gtr:impact>One of my students, Gregorio Dias, gave a short talk about Science (What is; How to do it; What is the purpose); explained the steps to become a scientist and available scholarships for Brazilians to perform research in Brazil and abroad. To this end, he also exemplified his own experience and how he reached Oxford University coming from a small city in Brazil; he gave a brief summary about the work that is performed in both research groups he belongs too; two students presented a 5-10min. seminar about national/international relevant diseases (i.e., Chinkungunya virus, Ebola virus, and Chagas Disease); they finished by having a practice class in DNA extraction from strawberry; importantly, students were stimulated to talk and interrupt Gregorio during the entire talk to ask questions and he also asked them several questions. Additionally, to stimulate their English, he bought English grammar books, English dictionaries, and a Harry Potter book (specially if they were talking about Oxford) and gave as prizes to the students who presented the seminars and to the students who correctly answered questions at the end of the practical class.

The students became highly interested by the discussion . Many asked several particular questions about science and what they need to do to become scientists. During the seminar presented by the students, specially about Chikungunya and Ebola viruses, Gregorio became very surprised with the level of relevant questions they raised. Actually, due time issue, he had to stop the discussion in some point to start the practical class. These schools have minimal equipment and structure for science laboratory, so the strawberry DNA extraction class was a good experiment that was able to be entirely performed and they were very excited about it. By the end, some of them asked me if Gregorio could give a second talk in another point and said they really enjoyed that time spent. The biology school teachers also told Gregorio they felt very thankful.</gtr:impact><gtr:outcomeId>54511a40081dd2.07274363</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Schools</gtr:primaryAudience><gtr:year>2014</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>blog - British Society of Gene and Cell Therapy</gtr:description><gtr:form>Engagement focused website, blog or social media channel</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>C28F0E49-5237-43A1-A754-FEB512667D13</gtr:id><gtr:impact>Loyal Liverpool, a student in the lab, wrote a piece on the discovery of a system similar to the bacterial CRISPR-Cas system in a giant virus for the first time (Levasseur et al 2016 Nature) for BSGCT Blogs.</gtr:impact><gtr:outcomeId>5756eb6d37e3c4.57907662</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.bsgct.org/4725-2/</gtr:url><gtr:year>2016</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Podcast</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>A607BABC-4072-49D6-B6B1-8977C4D383AA</gtr:id><gtr:impact>A podcast of about 5 min was recorded and is available online. It describes our research to the general public.

not determined</gtr:impact><gtr:outcomeId>r1apitGUMgR</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.ndm.ox.ac.uk/jan-rehwinkel-how-the-innate-immune-system-detects-flu-virus</gtr:url><gtr:year>2013</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>176440</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Enhancement Award</gtr:description><gtr:end>2018-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>CFDF3C9E-8EAE-498D-9706-9C167FE4BFF2</gtr:id><gtr:outcomeId>58be9d4114c8e0.11922368</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>281000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Multi-user Equipment Grant</gtr:description><gtr:end>2017-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>AF5D1DB5-13DB-4E0F-96BC-5AFBA41D7ADB</gtr:id><gtr:outcomeId>545118e09cef94.45512440</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2014-09-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>22000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Medical Research Foundation</gtr:department><gtr:description>Medical Research Foundation - Equipment Funds for Mid-Career Researchers</gtr:description><gtr:end>2013-09-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>7F540FB4-734B-445A-A254-0FF47643F2F8</gtr:id><gtr:outcomeId>hC99ynZHUm4</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-04-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>13500</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CGAT (Computational Genomics Analysis and Training)</gtr:description><gtr:end>2014-02-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>0074AE8F-8DDA-4173-AE05-5A57179C064F</gtr:id><gtr:outcomeId>iTbf43UzEtd</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-02-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>15000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CRUK Oxford Centre Development Fund</gtr:description><gtr:end>2016-06-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:id>E6AA81DE-A703-43FF-B41A-4B972CA44BAA</gtr:id><gtr:outcomeId>56cde25a34f242.90248660</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-07-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1053410</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust New Investigator Award</gtr:description><gtr:end>2018-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>6C9CD730-20E8-4E8F-87FA-EEBA3C867E43</gtr:id><gtr:outcomeId>RD4NsrPpMyq</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>273288</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>EUR</gtr:currCode><gtr:currCountryCode>Austria</gtr:currCountryCode><gtr:currLang>de_AT</gtr:currLang><gtr:description>Marie Sklodowska-Curie Actions Innovative Training Network (ITN)</gtr:description><gtr:end>2019-09-02</gtr:end><gtr:fundingOrg>European Union</gtr:fundingOrg><gtr:fundingRef>H2020-MSCA-ITN-2015</gtr:fundingRef><gtr:id>DF97B786-C26E-4869-98D2-03B55C870D98</gtr:id><gtr:outcomeId>58be9db2981696.20790728</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1085475</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Project Grant</gtr:description><gtr:end>2017-06-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>364F02A0-87E5-4056-B0F1-AD9D513DA7B6</gtr:id><gtr:outcomeId>545118846c8af0.60817884</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2014-06-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>50000</gtr:amountPounds><gtr:country>European Union (EU)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>EMBO Long-term postdoctoral fellowship to Dr Jonathan Maelfait</gtr:description><gtr:end>2014-09-02</gtr:end><gtr:fundingOrg>European Molecular Biology Organisation</gtr:fundingOrg><gtr:id>E1B5EA4B-1441-440B-AF4D-F6A7872990F4</gtr:id><gtr:outcomeId>i3hGRcfcgi4</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>25000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Centenary Early Career Award</gtr:description><gtr:end>2013-08-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>3CDAC4D2-B7F4-4128-9176-8862291C08E6</gtr:id><gtr:outcomeId>MjAsuTrji1a</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>200000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Lister Institute Research Prize Fellowship</gtr:description><gtr:end>2021-09-02</gtr:end><gtr:fundingOrg>Lister Institute of Preventive Medicine</gtr:fundingOrg><gtr:id>76D632B4-6251-482A-A3C4-E2188B7F2F19</gtr:id><gtr:outcomeId>58be9de8866cd7.89029537</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>A631845F-4BFA-4C9F-B6C0-317C5901A74F</gtr:id><gtr:title>A prosurvival DNA damage-induced cytoplasmic interferon response is mediated by end resection factors and is limited by Trex1.</gtr:title><gtr:parentPublicationTitle>Genes &amp; development</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a081b7ad9d3401878fdee97184bdc52c"><gtr:id>a081b7ad9d3401878fdee97184bdc52c</gtr:id><gtr:otherNames>Erdal E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0890-9369</gtr:issn><gtr:outcomeId>5aa591c6d78162.33135308</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>11006C5A-362C-4C7F-AE41-BAB0EA031711</gtr:id><gtr:title>SAMHD1-dependent retroviral control and escape in mice.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f73bda9f22c7c74fa4a798aa3795187"><gtr:id>9f73bda9f22c7c74fa4a798aa3795187</gtr:id><gtr:otherNames>Rehwinkel J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>pm_14598_28_23872947</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6F4E881A-1481-455C-958B-682192E8BC12</gtr:id><gtr:title>Antiviral immunity via RIG-I-mediated recognition of RNA bearing 5'-diphosphates.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/21d045fb63459b8f1bea0caf639c7296"><gtr:id>21d045fb63459b8f1bea0caf639c7296</gtr:id><gtr:otherNames>Goubau D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>545116fb972d29.01651166</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>538667E7-7A6F-49E6-B94E-15B5F41B75C9</gtr:id><gtr:title>Viruses transfer the antiviral second messenger cGAMP between cells.</gtr:title><gtr:parentPublicationTitle>Science (New York, N.Y.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3e491ba8e5b16c64ec3cb8b381ebef5a"><gtr:id>3e491ba8e5b16c64ec3cb8b381ebef5a</gtr:id><gtr:otherNames>Bridgeman A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0036-8075</gtr:issn><gtr:outcomeId>56cde0ab2e9866.03803410</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>30778F48-3B24-4266-B346-7828ED739692</gtr:id><gtr:title>Restriction by SAMHD1 Limits cGAS/STING-Dependent Innate and Adaptive Immune Responses to HIV-1.</gtr:title><gtr:parentPublicationTitle>Cell reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e75170981a64b65c50a8ff971c4d3eb2"><gtr:id>e75170981a64b65c50a8ff971c4d3eb2</gtr:id><gtr:otherNames>Maelfait J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>58be9c355fb024.15515439</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C133F1D4-7837-49A3-9431-6DA397A1D421</gtr:id><gtr:title>Identification of an LGP2-associated MDA5 agonist in picornavirus-infected cells.</gtr:title><gtr:parentPublicationTitle>eLife</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/3832189b34e50677a04af09f8e56c7cd"><gtr:id>3832189b34e50677a04af09f8e56c7cd</gtr:id><gtr:otherNames>Deddouche S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>2050-084X</gtr:issn><gtr:outcomeId>doi_14598_Life_01535</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AC340242-8154-4688-AC50-B045EC65EB64</gtr:id><gtr:title>Full Genome Sequence and sfRNA Interferon Antagonist Activity of Zika Virus from Recife, Brazil.</gtr:title><gtr:parentPublicationTitle>PLoS neglected tropical diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e8f028a0beb9437345f8ec909e45a6cb"><gtr:id>e8f028a0beb9437345f8ec909e45a6cb</gtr:id><gtr:otherNames>Donald CL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1935-2727</gtr:issn><gtr:outcomeId>58be9c34f01993.51196374</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A7B6513A-B43F-4968-BAEC-11AD51C5EB1E</gtr:id><gtr:title>B Cells Producing Type I Interferon Modulate Macrophage Polarization in Tuberculosis.</gtr:title><gtr:parentPublicationTitle>American journal of respiratory and critical care medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a66a08bcea4bb1c5525062abe11c81c6"><gtr:id>a66a08bcea4bb1c5525062abe11c81c6</gtr:id><gtr:otherNames>B?nard A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1073-449X</gtr:issn><gtr:outcomeId>5aa591c5dd1f49.62124794</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2AF70CE2-D314-4B19-B9D4-239C5634D9E1</gtr:id><gtr:title>Innate immune sensing of cytosolic chromatin fragments through cGAS promotes senescence.</gtr:title><gtr:parentPublicationTitle>Nature cell biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c057b6e44afce0cf7371b6ec7ec81424"><gtr:id>c057b6e44afce0cf7371b6ec7ec81424</gtr:id><gtr:otherNames>Gl?ck S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1465-7392</gtr:issn><gtr:outcomeId>5aa591c64aa7f8.66471221</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2F9558E2-B30A-414E-AC03-C1DF85F32CE4</gtr:id><gtr:title>SAMHD1 is mutated recurrently in chronic lymphocytic leukemia and is involved in response to DNA damage.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4d9e2cfdb7f97950d60449f515031345"><gtr:id>4d9e2cfdb7f97950d60449f515031345</gtr:id><gtr:otherNames>Clifford R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>doi_14598__04_490847</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D3F567CE-94C7-4398-A8C4-89A88D30F3E9</gtr:id><gtr:title>Is anti-viral defence the evolutionary origin of mRNA turnover? (Comment on DOI 10.1002/bies.201600100).</gtr:title><gtr:parentPublicationTitle>BioEssays : news and reviews in molecular, cellular and developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f73bda9f22c7c74fa4a798aa3795187"><gtr:id>9f73bda9f22c7c74fa4a798aa3795187</gtr:id><gtr:otherNames>Rehwinkel J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0265-9247</gtr:issn><gtr:outcomeId>58be9c352ea9a4.70973509</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>56C430A8-E929-40C8-A7A0-0B3C2268641D</gtr:id><gtr:title>Purification of Cyclic GMP-AMP from Viruses and Measurement of Its Activity in Cell Culture.</gtr:title><gtr:parentPublicationTitle>Methods in molecular biology (Clifton, N.J.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f675c3a1ad4bbd0f5a4b341771501d54"><gtr:id>f675c3a1ad4bbd0f5a4b341771501d54</gtr:id><gtr:otherNames>Mayer A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1064-3745</gtr:issn><gtr:outcomeId>5aa591c62664a0.21016759</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>075E5515-ABED-4990-AA8E-1273936B00E9</gtr:id><gtr:title>RNA sensing: the more RIG-I the merrier?</gtr:title><gtr:parentPublicationTitle>EMBO reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f73bda9f22c7c74fa4a798aa3795187"><gtr:id>9f73bda9f22c7c74fa4a798aa3795187</gtr:id><gtr:otherNames>Rehwinkel J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1469-221X</gtr:issn><gtr:outcomeId>pm_14598_28_23917614</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FA14D1D4-561B-48D3-B55C-FF14337489F6</gtr:id><gtr:title>Mouse superkiller-2-like helicase DDX60 is dispensable for type I IFN induction and immunity to multiple viruses.</gtr:title><gtr:parentPublicationTitle>European journal of immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/21d045fb63459b8f1bea0caf639c7296"><gtr:id>21d045fb63459b8f1bea0caf639c7296</gtr:id><gtr:otherNames>Goubau D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0014-2980</gtr:issn><gtr:outcomeId>56cde0aaef0a75.27720887</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>11F14DC5-DA55-49ED-A55E-4534AF2B4F13</gtr:id><gtr:title>Mouse knockout models for HIV-1 restriction factors.</gtr:title><gtr:parentPublicationTitle>Cellular and molecular life sciences : CMLS</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f73bda9f22c7c74fa4a798aa3795187"><gtr:id>9f73bda9f22c7c74fa4a798aa3795187</gtr:id><gtr:otherNames>Rehwinkel J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1420-682X</gtr:issn><gtr:outcomeId>545116b139ce07.24031473</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1D465EE9-3480-4339-AAED-5F8899439886</gtr:id><gtr:title>Sensing of viral and endogenous RNA by ZBP1/DAI induces necroptosis.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e75170981a64b65c50a8ff971c4d3eb2"><gtr:id>e75170981a64b65c50a8ff971c4d3eb2</gtr:id><gtr:otherNames>Maelfait J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>5aa591c680e839.65199756</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>60BD87F0-1D7D-4FCB-AC9C-D2894E23DFBC</gtr:id><gtr:title>Keeping your armour intact: how HIV-1 evades detection by the innate immune system: HIV-1 capsid controls detection of reverse transcription products by the cytosolic DNA sensor cGAS.</gtr:title><gtr:parentPublicationTitle>BioEssays : news and reviews in molecular, cellular and developmental biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e75170981a64b65c50a8ff971c4d3eb2"><gtr:id>e75170981a64b65c50a8ff971c4d3eb2</gtr:id><gtr:otherNames>Maelfait J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0265-9247</gtr:issn><gtr:outcomeId>doi_14598__201400019</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BD572C13-C1A7-4751-8749-EFDCAE641C2F</gtr:id><gtr:title>Targeting the viral Achilles' heel: recognition of 5'-triphosphate RNA in innate anti-viral defence.</gtr:title><gtr:parentPublicationTitle>Current opinion in microbiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9f73bda9f22c7c74fa4a798aa3795187"><gtr:id>9f73bda9f22c7c74fa4a798aa3795187</gtr:id><gtr:otherNames>Rehwinkel J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1369-5274</gtr:issn><gtr:outcomeId>pm_14598_28_23707340</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DB9E4A08-4F93-4211-B323-B208D40B2D08</gtr:id><gtr:title>A G1-like state allows HIV-1 to bypass SAMHD1 restriction in macrophages.</gtr:title><gtr:parentPublicationTitle>The EMBO journal</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/292b41fa56f474420b9e8bde21def9a9"><gtr:id>292b41fa56f474420b9e8bde21def9a9</gtr:id><gtr:otherNames>Mlcochova P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0261-4189</gtr:issn><gtr:outcomeId>58be9c34c2f6a7.89581035</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EE76C224-F353-4594-BAD8-0A798148BF74</gtr:id><gtr:title>RECONsidering Sensing of Cyclic Dinucleotides.</gtr:title><gtr:parentPublicationTitle>Immunity</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e75170981a64b65c50a8ff971c4d3eb2"><gtr:id>e75170981a64b65c50a8ff971c4d3eb2</gtr:id><gtr:otherNames>Maelfait J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1074-7613</gtr:issn><gtr:outcomeId>5aa591c6ae10c8.54854323</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6CDAE391-ABE2-4A86-B753-C9C9A8E11A18</gtr:id><gtr:title>RNA degradation in antiviral immunity and autoimmunity.</gtr:title><gtr:parentPublicationTitle>Trends in immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/2c76e2116fa9d1c79a6e53bc777fc701"><gtr:id>2c76e2116fa9d1c79a6e53bc777fc701</gtr:id><gtr:otherNames>Rigby RE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1471-4906</gtr:issn><gtr:outcomeId>56cde0ab7f3ad6.00967529</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">MC_UU_12010/8</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>